P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2014

Features

Letter to the Editor

Health Systems Are Capable of Handling a REMS

JoAnn Stubbings, BSPharm, MHCA

FDA Devotes New Resources to Upgrading Generic Drug Safety

But in Some Instances, the Industry Is Pushing Back

The Food and Drug Administration, concerned about the quality of the generic drugs that represent 84 percent of U.S. prescriptions, is looking more closely at foreign manufacturing plants and weighing other changes in the generic approval process.
Stephen Barlas

Mobile Devices and Apps for Health Care Professionals: Uses and Benefits

Health care professionals’ use of mobile devices is transforming clinical practice. Numerous medical software applications can now help with tasks ranging from information and time management to clinical decision-making at the point of care.
C. Lee Ventola, MS

After Disappointments, Alzheimer’s Researchers Seek Out New Paths

Biomarkers and Combination Therapies May Lead to Disease-Modifying Treatments, Experts Say

Developing a disease-modifying treatment for Alzheimer’s disease has stymied researchers. A collaborative re-examination of premises that guided disappointing earlier trials is under way, with talk of new targets and combination therapies.
Susan Worley

Meeting Highlights

American Academy of Dermatology and American College of Cardiology

Attendees at the American Academy of Dermatology meeting found heightened interest in psoriasis treatments. The American College of Cardiology meeting included sessions on heparin versus bivalirudin and a controversy over renal denervation.
Walter Alexander

Departments

That’s the Way We Do Things Around Here!

Your Actions Speak Louder Than Words When It Comes To Patient Safety

Matthew Grissinger, RPh, FASCP

Prescription: Washington

DEA Proposal on Hydrocodone Combination Products Divides Pharmacists

The Impacts on Pharmacy Workload and Prescription Drug Abuse Are at Issue

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Droxidopa (Northera) for neurogenic orthostatic hypotension, elosulfase alfa (Vimizim)for Morquio A syndrome, and sodium hyaluronate in phosphate-buffered saline (Monovisc) to address knee osteoarthritis
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Sofosbuvir: A New Oral Once-Daily Agent for the Treatment of Hepatitis C Virus Infection

Agnes Cha, PharmD, AAHIVP, BCACP; and Aliaksandr Budovich, PharmD